Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
poly mva
- Development stage
- Phase 1
- Lead developer
- Garnett McKeen Laboratory
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Poly MVA is a proprietary dietary supplement composed of a complex mixture of alpha-lipoic acid bound to palladium (lipoic acid-palladium complex), B vitamins (including B1, B2, and B12), N-acetyl-cysteine (NAC), formyl-methionine, vitamin C, trace minerals (such as molybdenum, rhodium, ruthenium), and various amino acids. It is designed to support cellular energy production by enhancing mitochondrial function and providing antioxidant effects. The palladium-lipoic acid complex is thought to facilitate the uptake of lipoic acid into cells and modulate cellular electrical activity. Poly MVA has been studied as an adjunctive therapy in conditions such as cancer and amyotrophic lateral sclerosis (ALS) for its potential immune-modulating properties and ability to reduce fatigue[1][2][3][4][5].
- Brand names
- Poly MVA
- Other names
- alpha-lipoic acid-palladium/vitamin/mineral supplementlipoic acid mineral complexPolyMVA
Beyond the preview
Go deeper on poly mva.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on poly mva.